Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by a tissue sample or imaging scan such as a CT or MRI.
- People aged 18 years or older.
- People whose liver cancer is at an advanced stage and cannot be surgically removed, as determined by their treating doctor.
Who may not be able to join:
- People whose liver cancer can be surgically removed, or for whom a targeted local treatment (such as one directed specifically at the tumour area) is still an option.
- People who have already received treatment for their liver cancer, either through medication that travels through the body or through a targeted local treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sukeshi Patel Arora, MD, Mays Cancer Center
Phone: 210-450-0507
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterize the Change in disease and treatment patterns of advanced hepatocellular carcinoma (HCC) in older patients in the US.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.